Patient care navigation and health copilot AI
AlignCare AI
AlignCare offers patient-chosen visit recording, Nora assistance, and Care Circle sharing. Patients can direct questions and sharing, but recipient-use restrictions limit care-partner advocacy. The terms give inconsistent descriptions of when invited recipients gain access.
Published September 8, 2026 as an AI-assisted draft. The public report separates documented facts, agency judgments and unresolved questions.
Summary judgment · 82 out of 100 toward patient-directed
AlignCare's consumer visit-recording/Nora app and Care Circle sharing, operated by Frannaks Healthcare Advisory LLC. Patient-selected, vendor-hosted assistance. Caregiver access has separate conditions from the patient's own records.
Patient-directed visit assistance, with mixed care-partner control
AlignCare offers patient-chosen visit recording, Nora assistance, and Care Circle sharing. Patients can direct questions and sharing, but recipient-use restrictions limit care-partner advocacy. The terms give inconsistent descriptions of when invited recipients gain access.
Patient agency
How this tool changes agency
Original recordings and transcripts can support checking summaries. A care partner's ability to translate that understanding into benefits advocacy is limited by the stated use condition, even if the interface makes sharing easy.
Which invitation statement matches production, correction/export workflows, AI processor identities, and whether narrow caregiver-use terms are intended to exclude authorized appeal preparation.
Patient agency assessment
Who sets and changes the goal?
The patient controls questions, reminders, and sharing. Care Circle restrictions materially narrow what an authorized care partner may do with received information. Patient authorship and care-partner agency are not identical here.
What can the patient understand, question, or do?
Original recordings and transcripts can support checking summaries. A care partner's ability to translate that understanding into benefits advocacy is limited by the stated use condition, even if the interface makes sharing easy.
Can the patient evaluate the conditions of use?
Training and deletion disclosures are more specific than the old report suggests. Conflicting invitation-access wording prevents a clear account of when disclosure starts. No claim is made about legal enforceability or actual implementation.
Text findings
Conditions of use
Published controls and their limits
Training and deletion disclosures are more specific than the old report suggests. Conflicting invitation-access wording prevents a clear account of when disclosure starts. No claim is made about legal enforceability or actual implementation.
What remains unknown?
Not tested or not established
Which invitation statement matches production, correction/export workflows, AI processor identities, and whether narrow caregiver-use terms are intended to exclude authorized appeal preparation.
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
Source-specific findings and retrieval limitations are recorded in the full report.
Review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Which invitation statement matches production, correction/export workflows, AI processor identities, and whether narrow caregiver-use terms are intended to exclude authorized appeal preparation. No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
AI-assisted draft · Medium for terms, low for actual access enforcement (AI-assisted draft)